Recording: New to MOUD Provider Training

Cost: Free! 

Questions? Email Lauren at lauren.t.quintana@cuanschutz.edu 

How: 

Click Here

What?

There is no longer a federal requirement for providers to submit a notice of intent or obtain a waiver to prescribe medication for opioid use disorder (MOUD).

However, most providers feel more comfortable with education and training. Our training with Dr. Mendez will help providers feel more confident and ready to treat patients with opioid use disorders (OUD). 

According to the SAMSHA website, “All practitioners who have a current DEA registration that includes Schedule III authority, may now prescribe buprenorphine for Opioid Use Disorder in their practice if permitted by applicable state law and SAMHSA encourages them to do so. SAMHSA and DEA are actively working on implementation of a separate provision of the Omnibus related to training requirements for DEA registration that becomes effective in June 2023.”

SAMSHA Website: https://www.samhsa.gov/medication-assisted-treatment/removal-data-waiver-requirement

Official DEA Announcement: https://www.deadiversion.usdoj.gov/pubs/docs/A-23-0020-Dear-Registrant-Letter-Signed.pdf

Who is Eligible?

Providers and providers in training which include physicians, nurse practitioners, physician assistants, clinical nurse specialists, certified nurse midwives, and certified registered nurse anesthetists are all eligible to complete the buprenorphine waiver training.

AMA Credit Designation Statement:

The American Society of Addiction Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Society of Addiction Medicine (ASAM) and the University of Colorado Anschutz Medical Campus. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CME Committee Reviewer

Edwin Salsitz, MD, DFASAM – No relevant financial disclosures

Presenters

David Mendez, MD, FASAM - No relevant financial disclosures

Planning Committee

David Mendez, MD, FASAM - No relevant financial disclosures

Lauren Quintana, MS - No relevant financial disclosures

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.